Hong Kong Water Utilities Stock News

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

To the annoyance of some shareholders, Yee Hop Holdings Limited ( HKG:1662 ) shares are down a considerable 30% in the...

Shanghai Conant Optical's (HKG:2276) stock is up by a considerable 35% over the past three months. Given the company's...

While it may not be enough for some shareholders, we think it is good to see the 7Road Holdings Limited ( HKG:797...

The last three months have been tough on WebX International Holdings Company Limited ( HKG:8521 ) shareholders, who...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Packaging industry in Hong Kong, you could be...

Key Insights The projected fair value for Plover Bay Technologies is HK$8.52 based on 2 Stage Free Cash Flow to Equity...

With a price-to-sales (or "P/S") ratio of 0.1x Golden Wheel Tiandi Holdings Company Limited ( HKG:1232 ) may be sending...

While China Renaissance Holdings Limited ( HKG:1911 ) shareholders have enjoyed a good week with stock up 14%, they...

It's nice to see the Zall Smart Commerce Group Ltd. ( HKG:2098 ) share price up 11% in a week. But will that heal all...

There wouldn't be many who think Century Energy International Holdings Limited's ( HKG:8132 ) price-to-sales (or "P/S...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

In late December 2025 and early January 2026, CSPC Pharmaceutical Group announced Chinese regulatory approvals to begin clinical trials for multiple innovative therapies, including an inhaled nintedanib for idiopathic pulmonary fibrosis, a novel aldosterone synthase inhibitor, a first-in-class diabetes triple-combination tablet, and a GLP‑1/GIP dual‑biased agonist injection for obesity. These clinical trial approvals highlight CSPC’s expanding innovation pipeline across respiratory,...

Key Insights Using the 2 Stage Free Cash Flow to Equity, MGM China Holdings fair value estimate is HK$23.25 MGM China...

Shandong Weigao Group Medical Polymer (HKG:1066) has had a rough three months with its share price down 12%. It is...

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone...

It is hard to get excited after looking at VSTECS Holdings' (HKG:856) recent performance, when its stock has declined...

Viewing insider transactions for China Medical System Holdings Limited's ( HKG:867 ) over the last year, we see that...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...